| Name | 2'-hydroxydaidzein |
|---|---|
| Synonyms |
2',4',7-trihydroxyisoflavone
4H-1-Benzopyran-4-one, 3-(2,4-dihydroxyphenyl)-7-hydroxy- 3-(2,4-dihydroxyphenyl)-7-hydroxychromen-4-one 3-(2,4-Dihydroxyphenyl)-7-hydroxy-4H-chromen-4-one 7,2',4'-trihydroxyisoflavone 2'-hydroxyformononetin |
| Description | 2′-Hydroxydaidzein is a metabolite. 2′-Hydroxydaidzein inhibits the release of chemical mediator from inflammatory cells. 2′-Hydroxydaidzein significantly inhibits lysozyme and β-glucuronidase release from rat neutrophils, which is stimulated with fMLP/CB, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 575.7±50.0 °C at 760 mmHg |
| Molecular Formula | C15H10O5 |
| Molecular Weight | 270.24 |
| Flash Point | 225.2±23.6 °C |
| Exact Mass | 270.052826 |
| PSA | 90.90000 |
| LogP | 2.81 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.732 |
|
~61%
7678-85-5 |
| Literature: Woodward, Michael D. Phytochemistry (Elsevier), 1980 , vol. 19, p. 921 - 928 |
|
~%
7678-85-5 |
| Literature: Visser, Frans R.; Lane, Geoffrey A. Australian Journal of Chemistry, 1987 , vol. 40, # 10 p. 1705 - 1711 |
|
~%
7678-85-5 |
| Literature: Wyeth Patent: US2003/87955 A1, 2003 ; US 20030087955 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |